HPV is the most commonly sexually transmitted disease and affects both men and women. To date, the focus has been on using the vaccine to prevent cervical cancer in women, rather than examining its effect on men.
Researchers from the University of California San Francisco took part in the study. They tracked more than 4,000 sexually active males aged 16-26 from 18 countries.
The findings are published in the New England Journal of Medicine.